Publications

Differences in risk factors for incident and recurrent preterm birth: a population-based linkage of 3.5 million births from the CIDACS birth cohort.

Rocha, AS; De Cássia Ribeiro-Silva, R; Fiaccone, RL; PAIXAO, ES; Falcão, IR; Alves, FJ O; Silva, NJ; Ortelan, N; RODRIGUES, LC; Ichihara, MY; De Almeida, MF; Barreto, ML;

2022

BMC MEDICINE, (2022).20 1 10.1186/s12916-022-02313-4.

The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria.

ADAMU, AL; Karia, B; Bello, MM; Jahun, MG; Gambo, S; Ojal, J; SCOTT, A; Jemutai, J; ADETIFA, IM;

2022

BMJ GLOBAL HEALTH, (2022).7 1 10.1136/bmjgh-2021-007080.

Network analysis of spreading of dengue, Zika and chikungunya in the state of Bahia based on notified, confirmed and discarded cases.

Santos, ES; Miranda, JG V; Saba, H; Skalinski, LM; V. Veiga, R; Costa, MD C N; Cardim, LL; PAIXÃO, ES; Barreto, ML; Teixeira, MG; Andrade, RF S;

2022

Frontiers in physics, (2022).10, 10.3389/fphy.2022.1047835.

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.

WATSON-JONES, D; Changalucha, J; WHITWORTH, H; Pinto, L; Mutani, P; Indangasi, J; Kemp, T; Hashim, R; Kamala, B; Wiggins, R; Songoro, T; CONNOR, N; Mbwanji, G; Pavon, MA; Lowe, B; Mmbando, D; KAPIGA, S; MAYAUD, P; De SanJosé, S; Dillner, J; HAYES, RJ; Lacey, CJ; BAISLEY, K;

2022

The Lancet Global health, (2022).10 10 10.1016/S2214-109X(22)00309-6.

How Climate Change May Threaten Progress in Neonatal Health in the African Region.

Nakstad, B; FILIPPI, V; Lusambili, A; Roos, N; Scorgie, F; Chersich, MF; Luchters, S; KOVATS, S;

2022

Neonatology, (2022).119 5 10.1159/000525573.

The Role of Parenting Interventions in Optimizing School Readiness for Children With Disabilities in Low and Middle Income Settings.

SMYTHE, T; Almasri, NA; Moreno Angarita, M; Berman, BD; Kraus de Camargo, O; Hadders-Algra, M; Lynch, P; Samms-Vaughan, M; Olusanya, BO;

2022

Frontiers in Pediatrics, (2022).10, 10.3389/fped.2022.927678.

Safety of the Ad26.ZEBOV/MVA-BN-Filo vaccine regimen in adults, children and pregnant women in DRC and immunogenicity of a delayed 2nd dose: the DRC-EB-001 trial.

WATSON-JONES, D;

2022

(2022).

Has Ebola delayed progress on access to routine care and financial protection in Sierra Leone? Evidence from a difference-in-differences analysis with propensity score weighting.

KING, J; SADIQUE, Z; Amara, M; BORGHI, J;

2022

Social science & medicine (1982), (2022).303, 10.1016/j.socscimed.2022.114995.

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.

WATSON-JONES, D; Kavunga-Membo, H; Grais, RF; Ahuka, S; Roberts, N; EDMUNDS, WJ; CHOI, EM; ROBERTS, CH; EDWARDS, T; Camacho, A; LEES, S; Leyssen, M; Spiessens, B; Luhn, K; Douoguih, M; Hatchett, R; Bausch, DG; Muyembe, J-J; DRC-EB-001 protocol writing team,;

2022

BMJ open, (2022).12 3 10.1136/bmjopen-2021-055596.

Prioritizing the mental health needs of pregnant adolescents in sub-Saharan Africa.

Eboreime, E; Ezeokoli, A; Adams, K; BANKE-THOMAS, A;

2022

Journal of Global Health Neurology and Psychiatry (2022). 10.52872/001c.34646.